A number of research firms have changed their ratings and price targets for Keryx Biopharmaceuticals (NASDAQ: KERX): 3/30/2016 – Keryx Biopharmaceuticals had its price target raised by analysts at FBR & Co. from $10.00 to $13.00. They now have an “outperform” rating on the stock. 3/29/2016 – Keryx Biopharmaceuticals had its “sell” rating reaffirmed by […]
